Immunosuppression (IS)
Showing 1 - 25 of >10,000
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient) Trial in San Francisco, Chicago,
Completed
- Liver Transplant Recipient
- Living Donor (of the Respective Liver Transplant Recipient)
- darTregs
- +4 more
-
San Francisco, California
- +2 more
Jan 21, 2021
Transplantation, Liver Trial in London, Newcastle (Biomarker, Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate
Active, not recruiting
- Transplantation, Liver
- Biomarker
- Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine
-
London, United Kingdom
- +1 more
Mar 10, 2021
Diabetes, Type 1, Diabetic Nephropathy Trial in Worldwide (sirolimus versus mycophenolate mofetil)
Completed
- Diabetes Mellitus, Type 1
- Diabetic Nephropathy
- sirolimus versus mycophenolate mofetil
-
Innsbruck, Austria
- +13 more
Aug 17, 2021
CNI Side Effects Trial in Minneapolis (Cyclosporine & Cellcept, Prograf & Cellcept, Low Dose CNI (Cyclosporine or FK) and
Completed
- CNI Side Effects
- Cyclosporine & Cellcept
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 17, 2020
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy Trial in Worldwide (Tacrolimus (for Group B),
Completed
- Disorder Related to Renal Transplantation
- Effects of Immunosuppressant Therapy
- Tacrolimus (for Group B)
- +5 more
-
Prague, Prague 4, Czechia
- +7 more
Jan 28, 2021
Stroke-induced Immunodepression in Neurorehabilitation
Completed
- Stroke
- +2 more
- Neurorehabilitation
-
Pavia, ItalyHeadache Science & Neurorehabilitation Center
Jun 1, 2023
Immune Dysregulation in Patients With COVID-19
Recruiting
- COVID-19
- Immunosuppression
- mid covid-19 patients
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 6, 2023
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)
Not yet recruiting
- Lung Transplant
- Tocilizumab
- Placebo for Tocilizumab
-
Phoenix, Arizona
- +16 more
Sep 8, 2023
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Rejection; Transplant, Liver, Liver Failure, Liver Diseases Trial in Cambridge, London (QEL-001)
Recruiting
- Rejection; Transplant, Liver
- +2 more
-
Birmingham, United Kingdom
- +3 more
Dec 22, 2022
Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)
Active, not recruiting
- Living Donor Liver Transplantation
- Donor-derived DCreg
-
Pittsburgh, PennsylvaniaUPMC
Sep 7, 2022
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Torque Teno Virus: A Biomarker of Immunosuppression
Recruiting
- Renal Transplant Rejection
- +3 more
- None Observational study
-
London, United KingdomRoyal London Hospital
Feb 23, 2023
Renal Transplantation Trial (TCD601, belatacept, ATG)
Not yet recruiting
- Renal Transplantation
- TCD601
- +5 more
- (no location specified)
Dec 20, 2022
DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,
Completed
- DiGeorge Anomaly
- +4 more
- Cultured Thymus Tissue for Implantation (CTTI)
- +8 more
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022
COVID-19 Trial in Australia (diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine)
Not yet recruiting
- COVID-19
- diphtheria and tetanus toxoids (adsorbed) vaccine
- COVID-19 vaccine
-
Blacktown, New South Wales, Australia
- +4 more
Nov 20, 2022
Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)
Not yet recruiting
- Renal Transplant Rejection
- Renal Transplant Infection
- (no location specified)
Nov 1, 2022
Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)
Withdrawn
- Metastatic Melanoma
- +5 more
- single arm
- (no location specified)
Dec 20, 2022
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Recruiting
- Kidney Transplant; Complications
- +2 more
- Blood Draw
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 21, 2022